nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—hypertension—adrenal gland cancer	0.707	1	CtDrD
Acebutolol—ABCB1—adrenal gland cancer	0.292	1	CbGaD
Acebutolol—Atenolol—ABCB1—adrenal gland cancer	0.000322	0.46	CrCbGaD
Acebutolol—Metoprolol—ABCB1—adrenal gland cancer	0.000251	0.359	CrCbGaD
Acebutolol—Propranolol—ABCB1—adrenal gland cancer	0.000126	0.181	CrCbGaD
Acebutolol—SLC22A1—Abacavir transmembrane transport—ABCB1—adrenal gland cancer	4.38e-05	0.115	CbGpPWpGaD
Acebutolol—SLC22A1—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	2.51e-05	0.066	CbGpPWpGaD
Acebutolol—ADRB2—Arf6 signaling events—TSHR—adrenal gland cancer	1.78e-05	0.0468	CbGpPWpGaD
Acebutolol—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	1.66e-05	0.0436	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—GNRHR—adrenal gland cancer	1.56e-05	0.0408	CbGpPWpGaD
Acebutolol—ADRB2—Arf6 trafficking events—TSHR—adrenal gland cancer	1.41e-05	0.037	CbGpPWpGaD
Acebutolol—ADRB1—Endothelin Pathways—GNAS—adrenal gland cancer	1.11e-05	0.0292	CbGpPWpGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	1.07e-05	0.0281	CbGpPWpGaD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	1.05e-05	0.0275	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	7.51e-06	0.0197	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—TSHR—adrenal gland cancer	6.63e-06	0.0174	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—TSHR—adrenal gland cancer	6.48e-06	0.017	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	5.92e-06	0.0155	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	5.79e-06	0.0152	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—KCNJ5—adrenal gland cancer	5.75e-06	0.0151	CbGpPWpGaD
Acebutolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	5.2e-06	0.0136	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—GNRHR—adrenal gland cancer	4.51e-06	0.0118	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—GNRHR—adrenal gland cancer	4.41e-06	0.0116	CbGpPWpGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	4.11e-06	0.0108	CbGpPWpGaD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	4.02e-06	0.0105	CbGpPWpGaD
Acebutolol—ADRB2—Arf6 signaling events—EGFR—adrenal gland cancer	3.95e-06	0.0104	CbGpPWpGaD
Acebutolol—ADRB2—Arf6 trafficking events—CTNNB1—adrenal gland cancer	3.94e-06	0.0103	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—GNAS—adrenal gland cancer	3.86e-06	0.0101	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—GNAS—adrenal gland cancer	3.77e-06	0.0099	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	3.55e-06	0.0093	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	3.47e-06	0.0091	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	3.46e-06	0.00908	CbGpPWpGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	3.33e-06	0.00873	CbGpPWpGaD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	3.26e-06	0.00854	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	3.22e-06	0.00844	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	3.16e-06	0.00829	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	3.09e-06	0.00811	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	2.88e-06	0.00755	CbGpPWpGaD
Acebutolol—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	2.79e-06	0.00731	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—GNRH1—adrenal gland cancer	2.7e-06	0.00708	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—GNRH1—adrenal gland cancer	2.64e-06	0.00693	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—POMC—adrenal gland cancer	2.6e-06	0.00681	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—GNRHR—adrenal gland cancer	2.55e-06	0.00668	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—POMC—adrenal gland cancer	2.54e-06	0.00666	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—GNRHR—adrenal gland cancer	2.49e-06	0.00654	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—TSHR—adrenal gland cancer	2.41e-06	0.00631	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—TSHR—adrenal gland cancer	2.35e-06	0.00618	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GNRHR—adrenal gland cancer	2.31e-06	0.00607	CbGpPWpGaD
Acebutolol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	2.27e-06	0.00596	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GNRHR—adrenal gland cancer	2.26e-06	0.00594	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—PRKACA—adrenal gland cancer	2.21e-06	0.00579	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	1.99e-06	0.00522	CbGpPWpGaD
Acebutolol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.84e-06	0.00483	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—SDHB—adrenal gland cancer	1.58e-06	0.00416	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	1.55e-06	0.00407	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—GNRH1—adrenal gland cancer	1.53e-06	0.004	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—GNRH1—adrenal gland cancer	1.49e-06	0.00392	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—GNAS—adrenal gland cancer	1.4e-06	0.00367	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GNRH1—adrenal gland cancer	1.39e-06	0.00364	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—GNAS—adrenal gland cancer	1.37e-06	0.00359	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GNRHR—adrenal gland cancer	1.37e-06	0.00358	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—TSHR—adrenal gland cancer	1.36e-06	0.00357	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GNRH1—adrenal gland cancer	1.36e-06	0.00356	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GNRHR—adrenal gland cancer	1.34e-06	0.00351	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—TSHR—adrenal gland cancer	1.33e-06	0.00349	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.27e-06	0.00333	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.24e-06	0.00326	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	1.24e-06	0.00325	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—TSHR—adrenal gland cancer	1.23e-06	0.00324	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	1.21e-06	0.00318	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—TSHR—adrenal gland cancer	1.21e-06	0.00317	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ZNRF3—adrenal gland cancer	1.19e-06	0.00313	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—BRAF—adrenal gland cancer	1.19e-06	0.00312	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.19e-06	0.00311	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ZNRF3—adrenal gland cancer	1.17e-06	0.00306	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	1.04e-06	0.00272	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—RRM1—adrenal gland cancer	1.02e-06	0.00268	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—SDHD—adrenal gland cancer	1.02e-06	0.00268	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	9.79e-07	0.00257	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	9.61e-07	0.00252	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	9.43e-07	0.00247	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—POMC—adrenal gland cancer	9.42e-07	0.00247	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SDHB—adrenal gland cancer	9.29e-07	0.00244	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—POMC—adrenal gland cancer	9.22e-07	0.00242	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PRKACA—adrenal gland cancer	8.86e-07	0.00233	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SDHB—adrenal gland cancer	8.75e-07	0.0023	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PRKACA—adrenal gland cancer	8.67e-07	0.00227	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CDC42—adrenal gland cancer	8.28e-07	0.00217	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GNRH1—adrenal gland cancer	8.18e-07	0.00215	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CDC42—adrenal gland cancer	8.1e-07	0.00212	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GNRH1—adrenal gland cancer	8.01e-07	0.0021	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—GNAS—adrenal gland cancer	7.91e-07	0.00208	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—GNAS—adrenal gland cancer	7.74e-07	0.00203	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	7.62e-07	0.002	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MED12—adrenal gland cancer	7.61e-07	0.002	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CDC42—adrenal gland cancer	7.52e-07	0.00197	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SPRY2—adrenal gland cancer	7.49e-07	0.00196	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CDC42—adrenal gland cancer	7.35e-07	0.00193	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SPRY2—adrenal gland cancer	7.32e-07	0.00192	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TSHR—adrenal gland cancer	7.29e-07	0.00191	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GNAS—adrenal gland cancer	7.18e-07	0.00188	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TSHR—adrenal gland cancer	7.14e-07	0.00187	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GNAS—adrenal gland cancer	7.03e-07	0.00184	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.95e-07	0.00182	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MEN1—adrenal gland cancer	6.86e-07	0.0018	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	6.82e-07	0.00179	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MEN1—adrenal gland cancer	6.71e-07	0.00176	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.98e-07	0.00157	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.98e-07	0.00157	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—RRM1—adrenal gland cancer	5.64e-07	0.00148	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SDHD—adrenal gland cancer	5.64e-07	0.00148	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.63e-07	0.00148	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PRKACA—adrenal gland cancer	5.55e-07	0.00146	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.4e-07	0.00142	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—POMC—adrenal gland cancer	5.33e-07	0.0014	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PRKACA—adrenal gland cancer	5.24e-07	0.00137	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—POMC—adrenal gland cancer	5.21e-07	0.00137	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PRKACA—adrenal gland cancer	5.12e-07	0.00134	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—POMC—adrenal gland cancer	4.84e-07	0.00127	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—POMC—adrenal gland cancer	4.73e-07	0.00124	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.53e-07	0.00119	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GNAS—adrenal gland cancer	4.5e-07	0.00118	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MED12—adrenal gland cancer	4.46e-07	0.00117	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDC42—adrenal gland cancer	4.44e-07	0.00117	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ABCB1—adrenal gland cancer	4.42e-07	0.00116	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDC42—adrenal gland cancer	4.34e-07	0.00114	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF2—adrenal gland cancer	4.28e-07	0.00112	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GNAS—adrenal gland cancer	4.24e-07	0.00111	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MED12—adrenal gland cancer	4.2e-07	0.0011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF2—adrenal gland cancer	4.19e-07	0.0011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GNAS—adrenal gland cancer	4.15e-07	0.00109	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF1R—adrenal gland cancer	4.14e-07	0.00109	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF1R—adrenal gland cancer	4.05e-07	0.00106	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TERT—adrenal gland cancer	3.56e-07	0.000935	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TERT—adrenal gland cancer	3.48e-07	0.000914	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.25e-07	0.000854	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BAD—adrenal gland cancer	3.1e-07	0.000813	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	3.07e-07	0.000805	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BAD—adrenal gland cancer	3.03e-07	0.000795	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—POMC—adrenal gland cancer	3.03e-07	0.000795	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—POMC—adrenal gland cancer	2.86e-07	0.00075	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BRAF—adrenal gland cancer	2.82e-07	0.00074	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—POMC—adrenal gland cancer	2.79e-07	0.000733	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BRAF—adrenal gland cancer	2.76e-07	0.000724	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EGFR—adrenal gland cancer	2.73e-07	0.000718	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EGFR—adrenal gland cancer	2.67e-07	0.000702	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.64e-07	0.000692	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.49e-07	0.000652	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.44e-07	0.00064	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—adrenal gland cancer	2.42e-07	0.000634	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.04e-07	0.000535	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.99e-07	0.000523	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—POMC—adrenal gland cancer	1.78e-07	0.000466	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.67e-07	0.000439	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGFR—adrenal gland cancer	1.62e-07	0.000424	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGFR—adrenal gland cancer	1.58e-07	0.000415	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.42e-07	0.000372	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TP53—adrenal gland cancer	1.36e-07	0.000356	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.34e-07	0.00035	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TP53—adrenal gland cancer	1.33e-07	0.000348	CbGpPWpGaD
